Sulpiride injections into the medial septum reverse the influence of intra-medial septum injection of L-arginine on expression of place conditioning-induced by morphine in rats

Brain Research

Volumn 976, Issue 1, 2003, Pages 30-40

  Karami, Manizheh ^a,c   Zarrindast, Mohammad Reza ^b   Sepehri, Hori ^c   Sahraei, Hedayat ^d  

^a SHAHED UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

^d BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Conditioned place preference; L Arginine; Medial septum; Morphine; NG Nitro L arginine methyl ester (L NAME); Nitric oxide (NO); Rat; Sulpiride

Indexed keywords

ARGININE; DOPAMINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; MORPHINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OPIATE; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVERSION; CONDITIONING; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; DRUG EFFECT; LOCOMOTION; MALE; NONHUMAN; PLACE PREFERENCE; PRECURSOR; PRIORITY JOURNAL; RAT; SEPTUM PELLUCIDUM; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE;

EID: 0038066626     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02623-4     Document Type: Article

References (68)

1. Beninger R.J., Miller R. Dopamine D1-like receptors and reward-related incentive learning. Neurosci. Biobehav. Rev. 22:1997;335-345.
2. Bevins R.A., Bardo M.T. Morphine-conditioned changes in locomotor activity: role of the conditioned stimulus. Exp. Clin. Psychopharmacol. 6:1998;131-138.
3. Biala G., Langwinski K. Rewarding properties of some drugs studied by place preference conditioning. Pol. J. Pharmacol. 48:1996;425-430.
4. Bowyer J.F., Clausing P., Gough B., Slikker W. Jr., Holson R.R. Nitric oxide regulation of methamphetamine-induced dopamine release in caudate/putamen. Brain Res. 699:1995;62-70.
5. Bozarth M.A., Pudiak C.M., Morris M. Nitric oxide synthesis inhibition does not affect brain stimulation reward. Pharmacol. Biochem. Behav. 48:1994;487-490.
6. Carr G.D., White N.M. Anatomical disassociation of amphetamine's rewarding and aversive effects: an intra cranial microinjection study. Psychopharmacology (Berlin). 89:1986;340-346.
7. Carr G.D., White N.M. Conditioned place preference from intra-accumbens but not intra-caudate amphetamine injections. Life Sci. 33:1983;2551-2557.
8. Chapman P.F., Atkins C.M., Allen M.T., Haley J.E., Steinmets J.E. Inhibition of nitric oxide synthesis impairs two different forms of learning. Neuroreport. 3:1992;567-570.
9. Dawson T.M., Bredt D.S., Fotuhi M., Hwang P.M., Snyder S.H. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc. Natl. Acad. Sci. USA. 88:1991;7797-7801.
10. De Fonseca F.R., Rubio P., Calderon J.L.M., Caine S.B., Koob G.F., Navarro M. The dopamine receptor agonist 7-OH-DPTA modulates the acquisition and expression of morphine-induced place preference. Eur. J. Pharmacol. 274:1995;47-55.
11. Desvignes C., Bret L., Vinet L., Denoroy L., Renaud B., Lambas-Senas L. Evidence that the neural nitric oxide synthase inhibitor 7-nitroindasole inhibits monoamine oxidase in the rat: in vivo effects on extracellular striatal dopamine and 3,4-dihydroxyphenylacetic acid. Neurosci. Lett. 249:1999;5-8.
12. Ebstein R.P., Benjamin J., Gritsenke I., Kotler M. Dopamine system. Bolis C.L., Pani L., Licinio J. Dopaminergic System, Evolution From Biology To Clinical Aspects. 2001;Lippincott Williams and Wilkins Healthcare.
13. El-Husseini A.E.D., Bladen C., Vinsent S.R. Molecular characterization of a type-II cyclic GMP-dependent protein-kinase expressed in the rat-brain. J. Neurochem. 64:1995;2814-2817.
14. El-Husseini A.E.D., Williams J., Reiner P.B., Pelech S., Vincent S.R. Localization of the cGMP-dependent protein kinases in relation to nitric oxide synthase in the brain. J. Chem. Neuroanat. 17:1999;45-55.
15. Garthwaite J., Charle S.L., Chess-Williams R. Endothelium derived relaxing factor release on activation of NMDA receptors suggests role as intracellular messenger in the brain. Nature. 336:1988;385-388.
16. Gholami A., Zarrindast M.R., Sahraei H., Haeri-Rohani A. Nitric oxide within the ventral tegmental area is involved in mediating morphine reward. Eur. J. Pharmacol. 458:2003;119-128.
17. Goodman R.R., Pasternak G.W. Visualization of mu1 opiate receptors in rat brain by using a computerized autoradiographic subtraction technique. Proc. Natl. Acad. Sci. USA. 82:1985;6667-6671.
18. 3H]-dopamine from striatal slices. Neuroreport. 3:1992;409-412.
19. Hasko G., Szabo C., Merkel K., Bencsis A., Zingarelli B., Kvetan V., Vizi E.S. Modulation of lipopolysaccharide-induced tumor necrosis factor-α and nitric oxide production by dopamine receptor agonists and antagonists in mice. Immunol. Lett. 49:1996;143-147.
20. Itzhak Y., Martin J.L. Blockade of alcohol-induced locomotor sensitization and conditioned place preference in DBA mice by 7-nitroindazole. Brain Res. 858:2000;402-407.
21. Itzhak Y., Martin J.L., Black M.D., Huang P.L. The role of neuronal nitric oxide synthase in cocaine-induced conditioned place preference. Neuroreport. 9:1998;2485-2488.
22. Jaworski J.N., Gonzales R.A., Randall P.K. Effect of dopamine D2/D3 receptor antagonist sulpiride on amphetamine-induced changes in striatal extracellular dopamine. Eur. J. Pharmacol. 418:2001;201-206.
23. Kano T., Shimizu-Sasamata M., Huang P.L., Moskowitz M.A., Lo E.H. Effects of nitric oxide synthase gene knockout on neurotransmitter release in vivo. Neuroscience. 86:1998;695-699.
24. Kao P.C., Schroeder R.A. The emerging multifaceted roles of nitric oxide. Ann. Surg. 221:1995;220-235.
25. Karami M., Zarrindast M.R., Sepehri H., Sahraei H. Role of nitric oxide in the rat hippocampal CA1 area on morphine-induced place preference. Eur. J. Pharmacol. 449:2002;113-119.
26. Kim H., Park W. Nitric oxide mediation of cocaine-induced dopaminergic behaviors: ambulation-accelerating activity, reverse tolerance and conditioned place preference in mice. J. Pharmacol. Exp. Ther. 275:1995;551-557.
27. Kimes S.A., Vaupel D.M., London E.D. Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase. Psychopharmacology. 112:1993;521-524.
28. Kiss J.P., Hennings E.C., Zsilla G., Vizi E.S. A possible role of nitric oxide in the regulation of dopamine transporter function in the striatum. Neurochem. Int. 34:1999;345-350.
29. Kitchener P.D., Diamond J. Distribution and colocalization of choline acetyltransferase immunoreactivity and NADPH diaphorase reactivity in neurons within the medial septum and diagonal band of broca in the rat basal forebrain. J. Comp. Neurol. 335:1993;1-15.
30. Kivastik T., Rutkauskaite J., Zharkovsky A. Nitric oxide synthesis inhibition attenuates morphine-induced place preference. Pharmacol. Biochem. Behav. 53:1996;1013-1015.
31. Kolesnikov Y.A., Pick C.G., Pasternak G.W. NG-Nitro-L-arginine prevents morphine tolerance. Eur. J. Pharmacol. 221:1992;339-400.
32. Koob G.F., Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-723.
33. Lancaster J.R. Jr. Nitric oxide in cells. Am. Sci. 80:1992;248-259.
34. Liang L.P., Kaufman S. The regulation of dopamine release from striatum slices by tetrahydrobiopterin and L-arginine derived nitric oxide. Brain Res. 800:1998;181-186.
35. Lorrian D.S., Hull E.M. Nitric oxide increase dopamine and serotonin release in the medial preoptic area. Neuroreport. 5:1993;87-89.
36. Lowenstein C.J., Dinerman J.L., Snyder S.H. Nitric oxide: a physiologic messenger. Ann. Intern. Med. 120:1994;227-237.
37. Lu L., Xu N.J., Ge X., Yue W., Su W.J., Pei G., Ma L. Reactivation of morphine conditioned place preference by drug priming: role of environmental cues and sensitization. Psychopharmacology. 159:2002;125-132.
38. Meller S.T., Gebhart G.F. Nitric oxide and nociceptive processing in the spinal cord. Pain. 52:1993;127-136.
39. Miller R., Wickens J.R., Beninger R.J. Dopamine D1 and D2 receptors in relation to reward and performance: a case for the D1 receptor as a primary site of therapeutic action of neuroleptic drugs. Prog. Neurobiol. 34:1990;143-183.
40. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142.
41. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. New Engl. J. Med. 329:1993;2002-2012.
42. Ohno M., Arai I., Watanabe S. N-Methyl-D-aspartate dopamine release through nitric oxide formation in the nucleus accumbens of rats. Brain Res. 699:1995;332-335.
43. Olmstead M.C., Franklin K.B.J. The development of a conditioned place preference: effects of lesions of various CNS sites. Behav. Neurosci. 111:1997;1313-1323.
44. Overton D.A. State-dependent learning produced by addicting drugs. Fisher S., Freedman A.M. Opiate Addiction: Origin and Treatments. 1973;61-75 Winston, Washington, DC.
45. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd Edition:1987;Academic Press, Harcourt Brace Jovanovich Publisher.
46. Peng Z.C., Chen S., Bertini G., Schmidt H.H.H.W., Bentivoglio M. Colocalization of nitric-oxide synthase and NGF receptor in neurons in the medial septal and diagonal band nuclei of the rat. Neurosci. Lett. 166:1994;153-156.
47. Pulvirenti L., Balducci C., Koob G.F. Inhibition of nitric oxide synthesis reduces intravenous cocaine self-administration in the rat. Neuropharmacology. 35:1996;1811-1814.
48. Pulvirenti L., Maldonado R., Koob G.F. NMDA receptors in the nucleus accumbens modulate intravenous cocaine, but not heroin self-administration in the rat. Brain Res. 594:1992;327-330.
49. Ragozzino M.F., Gold P.F. Glucose-injections into the medial septum reverses the effects of intraseptal morphine infusions on hippocampal acetylcholine output and memory. Neuroscience. 68:1995;981-988.
50. Segieth J., Fowler I., Whitton P., Pearce B. Nitric oxide-mediated regulation of dopamine release in the hippocampus in vivo. Neuropharmacology. 39:2000;571-577.
51. Seheggi S., Masi F., Tagliamonte A., Gambarana C., Tolu P., De Montis P.M.G. Rats sensitized to morphine are resistant to the behavioral effects of an unavoidable stress. Brain Res. 853:2000;290-298.
52. Shibata M., Araki N., Ohta K., Hamada J., Shimau K., Fukuuchi Y. Nitric oxide regulate NMDA-induced dopamine release in rat striatum. Neuroreport. 7:1996;605-608.
53. Shippenberg T.S., Heidbreder Ch., Lefevour A. Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics. J. Pharmacol. Exp. Ther. 273:1996;808.
54. Snyder S.H. Nitric oxide: first in a new class of neurotransmitters? Science. 257:1992;494-496.
55. Stahle L. Do autoreceptors mediate dopamine agonist-induced yawning and suppression of exploration? A critical review. Psychopharmacology. 106:1992;1-13.
56. Stewart T.I., Michel A.D., Black M.D., Humphery P.P.A. Evidence that nitric oxide causes calcium-dependent release of [3H]dopamine from rat striatum in vitro. J. Neurochem. 66:1996;131-137.
57. Storey V.J., Middlemiss D.N., Reavill C. Effect of haloperidol and (-) sulpiride on dopamine agonist-induced hypoactivity. Neuropharmacology. 34:1995;449-455.
58. Strasser A., McCarron R.M., Ishii H., Stanimirovic D., Spatz M. L-Arginine induces dopamine release from the striatum in vivo. Neuroreport. 5:1994;2298-2300.
59. Sukhotina I.A. Morphine withdrawal-facilitated aggression is attenuated by morphine-conditioned stimuli. Pharmacol. Biochem. Behav. 68:2001;93-98.
60. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56:1998;613-672.
61. Vaupel D.B., Kimes A.S., London E.A. Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment withdrawal. Neuropharmacology. 13:1995;315-322.
62. Vaupel D.B., Kimes A.S., London E.D. Further in vivo studies on attenuating morphine withdrawal isoform-selective nitric oxide synthase inhibitors differs in efficacy. Eur. J. Pharmacol. 324:1997;11-20.
63. Wise R.A. The role of reward pathways in the development of drug dependence. Pharmacol. Ther. 35:1987;227-263.
64. Yamada K., Nabeshima T. Nitric oxide and cyclic GMP signaling pathway in learning and memory processes. Curr. Top. Pharmacol. 4:1998;77-86.
65. Yamada K., Noda Y., Nakayama S., Komori Y., Sugihara H., Hasegawa T., Nabeshima T. Role of nitric oxide in learning and memory and in dopamine metabolism in the rat brain. Br. J. Pharmacol. 115:1995;852-858.
66. Zarrindast M.R., Zarghi A. Morphine stimulates locomotor activity by an indirect dopaminergic mechanism: possible D-1 and D-2 receptor involvement. Gen. Pharmacol. 23:1992;1221-12125.
67. Zhou T.L., Tamura R., Kuriwaki J., Ono T. Comparison of medial and lateral septal neuron activity during performance of spatial tasks in rats. Hippocampus. 9:1999;220-234.
68. Zhu X.-Z., Luo L.-G. Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices. J. Neurochem. 59:1992;932-935.